Tumor-Host Interactions: A Far-Reaching RelationshipMCALLISTER, Sandra S; WEINBERG, Robert A.Journal of clinical oncology. 2010, Vol 28, Num 26, pp 4022-4028, issn 0732-183X, 7 p.Article

The invasive front of carcinomas. The most important area for tumour prognosis?BRYNE, M; BOYSEN, M; G.ALFSEN, C et al.Anticancer research. 1998, Vol 18, Num 6B, pp 4757-4764, issn 0250-7005Article

Orosomucoid: prealbumin ratio ― A marker of the host-tumor relationship in head and neck cancerCALDANI, C; THYSS, A; SCHNEIDER, M et al.European journal of cancer & clinical oncology. 1988, Vol 24, Num 4, pp 653-657, issn 0277-5379Article

Extracellular Matrix and DiseaseBOSMAN, Fred T; STAMENKOVIC, Ivan.Journal of pathology. 2003, Vol 200, Num 4, issn 0022-3417, 127 p.Serial Issue

Innaste Host Antitumour Immunity and Tumour ProgressionDEICHMAN, Galiba I.Seminars in cancer biology. 2002, Vol 12, Num 4, issn 1044-579X, 69 p.Serial Issue

Reflections on human tumor immunologyKLEIN, E.Medical oncology and tumor pharmacotherapy. 1993, Vol 10, Num 1-2, pp 83-86, issn 0736-0118Article

Interchange of amino acids between tumor and hostMEDINA, M. A; MARQUEZ, J; NUNEZ DE CASTRO, I et al.Biochemical medicine and metabolic biology. 1992, Vol 48, Num 1, pp 1-7, issn 0885-4505Article

Interferons in host defenseFALTYNEK, C. R; OPPENHEIM, J. J.Journal of the National Cancer Institute. 1988, Vol 80, Num 3, pp 151-153, issn 0027-8874Article

Cancer prevention by retinoids: role of immunological modificationWATSON, R. R; MORIGUCHI, S.Nutrition research (New York, NY). 1985, Vol 5, Num 6, pp 663-675, issn 0271-5317Article

Production of antitumor T-cells in tumor-bearing mice treated with tumor vaccine and 6-mercaptopurineKATAOKA, T; OH-HASHI, F.Cancer research (Baltimore). 1985, Vol 45, Num 7, pp 2962-2966, issn 0008-5472Article

Multiple cancers: tumor burden permits the outgrowth of other cancersMULLEN, C. A; URBAN, J. L; VAN WAES, C et al.The Journal of experimental medicine. 1985, Vol 162, Num 5, pp 1665-1682, issn 0022-1007Article

The microenvironment of the tumour-host interface : CancerLIOTTA, Lance A; KOHN, Elise C.Nature (London). 2001, Vol 411, Num 6835, pp 375-379, issn 0028-0836Article

Regulation of tumor-host interactions in breast cancerDICKSON, R. B.Journal of steroid biochemistry and molecular biology. 1992, Vol 41, Num 3-8, pp 389-400, issn 0960-0760Conference Paper

Metabolic responses to tumour disease and progression : tumour-host interactionCRAVO, M. L; GLORIA, L. M; CLARO, I et al.Clinical nutrition (Edinburgh). 2000, Vol 19, Num 6, pp 459-465, issn 0261-5614Article

Pharmacie et nutrition rôle des acides aminés dans la relation hôte-tumeur : Aspects physiopathologiques et thérapeutiques : Pharmacie et nutrition = Role of amino acids in the host-tumor relationship : from pathophysiology to therapeutics : Pharmacy and nutritionCYNOBER, L.Annales pharmaceutiques françaises. 2000, Vol 58, Num 6, pp 452-454, issn 0003-4509, SUPArticle

Selection of metastatic tumour phenotypes by host immune systemsSEYMOUR, K; PETTIT, S; O'FLAHERTY, E et al.Lancet (British edition). 1999, Vol 354, Num 9194, pp 1989-1991, issn 0140-6736Article

Paraneoplastic syndromes: MechanismsHALL, T. C.Seminars in oncology. 1997, Vol 24, Num 3, pp 269-276, issn 0093-7754Article

Tumor-host relationship : The viewpoint of an immunologist towards applied mathematiciansFORNI, G.Mathematical and computer modelling. 1996, Vol 23, Num 6, pp 89-94, issn 0895-7177Article

L'alpha-cétoglutarate d'ornithine (ACO) : un modulateur de l'immunité et de la relation hôte-tumeur = The alpha-cetoglutarate of ornithine (ACO) : a modulator of immunity and of the relation host-tumorLE BRICON, T; CYNOBER, L.Médecine et hygiène. 1995, Vol 53, Num 2087, pp 1970-1975, issn 0025-6749, 4 p.Article

Prospects for use of microgravity-based bioreactors to study three-dimensional host-tumor interactions in human neoplasiaJESSUP, J. M; GOODWIN, T. J; SPAULDING, G et al.Journal of cellular biochemistry. 1993, Vol 51, Num 3, pp 290-300, issn 0730-2312Article

Glutamine and cancerSOUBA, W. W.Annals of surgery. 1993, Vol 218, Num 6, pp 715-728, issn 0003-4932Article

Coagulation and fibrinolysis in cancerHEIMBURGER, N; PAQUES, E.-P; RÖMISCH, J et al.Behring-Institute-Mitteilungen. 1992, Num 91, pp 169-182, issn 0301-0457Article

Animal experiments on the role of T lymphocytes in the course of antineoplastic chemotherapy. I: Chemotherapy and tumor-specific immunityBIER, H; BIER, J.ORL. 1987, Vol 49, Num 1, pp 48-55, issn 0301-1569Article

Quantitative assay of plasma and urinary peptides as an aid for the evaluation of cancer patients undergoing antineoplaston therapyLIAU, M. C; SZOPA, M; BURZYNSKI, B et al.Drugs under experimental and clinical research. 1987, Vol 13, pp 61-70, issn 0378-6501, suppl. 1Article

Benign autoimmunity to combat malignancySTAUSS, H. J.Clinical and experimental immunology (Print). 2001, Vol 125, Num 1, pp 1-2, issn 0009-9104Article